CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

STAT News
High ImpactOriginal article

STAT+: Argenx to buy Forte Biosciences for $2.2B

Positive
AI Analysis

Summary

Argenx plans to acquire Forte Biosciences for $2.2 billion to expand its pipeline of drugs targeting multiple autoimmune diseases.

Importance:8/10
Sentiment:
0.60
M&Aacquisitionautoimmunepipeline expansion
Related Companies

Read the original article

Published by STAT News on July 27, 2026 7:26 AM

Read Original